181 related articles for article (PubMed ID: 18765229)
1. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
Gal H; Pandi G; Kanner AA; Ram Z; Lithwick-Yanai G; Amariglio N; Rechavi G; Givol D
Biochem Biophys Res Commun; 2008 Nov; 376(1):86-90. PubMed ID: 18765229
[TBL] [Abstract][Full Text] [Related]
2. A rapid assay for drug sensitivity of glioblastoma stem cells.
Gal H; Makovitzki A; Amariglio N; Rechavi G; Ram Z; Givol D
Biochem Biophys Res Commun; 2007 Jul; 358(3):908-13. PubMed ID: 17512905
[TBL] [Abstract][Full Text] [Related]
3. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
4. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
5. Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.
Shi L; Wan Y; Sun G; Gu X; Qian C; Yan W; Zhang S; Pan T; Wang Z; You Y
Neuromolecular Med; 2012 Dec; 14(4):303-16. PubMed ID: 22711523
[TBL] [Abstract][Full Text] [Related]
6. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2.
Wu N; Xiao L; Zhao X; Zhao J; Wang J; Wang F; Cao S; Lin X
FEBS Lett; 2012 Nov; 586(21):3831-9. PubMed ID: 22999819
[TBL] [Abstract][Full Text] [Related]
7. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
8. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.
Li H; Yang BB
Oncotarget; 2012 Dec; 3(12):1653-68. PubMed ID: 23391506
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
Zhao S; Deng Y; Liu Y; Chen X; Yang G; Mu Y; Zhang D; Kang J; Wu Z
Mol Biol Rep; 2013 Apr; 40(4):2789-98. PubMed ID: 23397238
[TBL] [Abstract][Full Text] [Related]
10. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.
Ying M; Wang S; Sang Y; Sun P; Lal B; Goodwin CR; Guerrero-Cazares H; Quinones-Hinojosa A; Laterra J; Xia S
Oncogene; 2011 Aug; 30(31):3454-67. PubMed ID: 21383690
[TBL] [Abstract][Full Text] [Related]
12. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
13. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.
Dong Y; Han Q; Zou Y; Deng Z; Lu X; Wang X; Zhang W; Jin H; Su J; Jiang T; Ren H
Mol Cell Biochem; 2012 Nov; 370(1-2):89-102. PubMed ID: 22829019
[TBL] [Abstract][Full Text] [Related]
14. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
[TBL] [Abstract][Full Text] [Related]
15. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133
Yang L; Li N; Yan Z; Li C; Zhao Z
J Mol Neurosci; 2018 Nov; 66(3):369-377. PubMed ID: 30267383
[TBL] [Abstract][Full Text] [Related]
16. Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
Pirson L; Baron F; Meuris N; Giet O; Castermans E; Greimers R; Di Stefano I; Gothot A; Beguin Y
Stem Cells; 2006 Jul; 24(7):1814-21. PubMed ID: 16614006
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.
Floyd DH; Zhang Y; Dey BK; Kefas B; Breit H; Marks K; Dutta A; Herold-Mende C; Synowitz M; Glass R; Abounader R; Purow BW
PLoS One; 2014; 9(5):e96239. PubMed ID: 24805821
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance genes in normal and cancer stem cells.
Shervington A; Lu C
Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin.
Lottaz C; Beier D; Meyer K; Kumar P; Hermann A; Schwarz J; Junker M; Oefner PJ; Bogdahn U; Wischhusen J; Spang R; Storch A; Beier CP
Cancer Res; 2010 Mar; 70(5):2030-40. PubMed ID: 20145155
[TBL] [Abstract][Full Text] [Related]
20. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
